Alpha small company research 

Exploit this biotech investor's huge margin of safety

Exploit this biotech investor's huge margin of safety
  • Pro forma net cash position accounts for 73 per cent of market capitalisation.
  • Portfolio of investee companies in the price for 67 per cent below estimated book value.
  • Board restructured and operating costs being significantly reduced.

To continue reading, subscribe to Alpha today

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now